Viking Therapeutics VKTX Earnings Call Transcripts

NASDAQ VKTX
$28.44 -0.22 (-0.77%)
At close: Nov 11, 2026 · 4:00 PM EST
14 earnings calls on file for Viking Therapeutics, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Viking Therapeutics Q3 2026 Earnings Call

Oct 28, 2026 8,029 words · 35 min read
  • Stephanie DiazManager of Investor Relations
  • Brian LianPresident and Chief Executive Officer
  • Gregory ZanteChief Financial Officer
  • Hubert ChenChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Viking Therapeutics Earnings Call Transcripts

Calls14
LatestOct 28, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 14 Viking Therapeutics transcripts Register to get access to Viking Therapeutics’s earnings call transcripts.